FDA Deputy Commissioner Moves On to Mylan
May 1st, 2013 // 2:22 pm @ jmpickett
Updated Daily – Read our latest FDA, cGMP Compliance News
Deborah Autor, Deputy Commissioner at FDA for Global Operations and Policy, is leaving the agency and will take a job with Mylan Pharmaceuticals. It is common for FDA personnel to leave the agency for private sector jobs, but this is a very high profile move that we don’t see every day.
When FDA Commissioner Margaret Hamburg announced the move, she said that Autor supervised 4 agency directorates that were created in 2011. She also oversaw the Office of Regulatory Affairs and the Office of Internat. Programs. Overall, she supervised 4500 FDA employees that handle imports, audits and enforcement and compliance. Earlier in her career, Autor was in charge of the Office of Compliance for CDER.
Autor stated in her announcement to FDA that Mylan is a leading company that promotes a single quality standard, which you can see in Mylan’s major role in developing FDASIA, or the FDA Safety and Innovation Act.
For now, John Taylor, who is at this time the Counselor to Hamburg, is going to be the interim Deputy Commissioner for Global Regulatory Operations and Policy.
